Cabaletta Bio, Inc.

CABA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 14, 2026 8-K
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
SCHEDULE 13G/A Aug 12, 2026
SCHEDULE 13G Aug 12, 2026
SCHEDULE 13G Jul 31, 2026
SCHEDULE 13G Jul 27, 2026
SCHEDULE 13G/A Jul 23, 2026
8-K Jun 11, 2026 8-K
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
SCHEDULE 13G/A Jun 5, 2026
SCHEDULE 13G/A Jun 4, 2026
8-K Jun 3, 2026 8-K
DEFA14A Jun 1, 2026 DEFA14A
SCHEDULE 13G/A May 15, 2026
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
8-K May 14, 2026 8-K
← Newer Page 1 of 18 · 444 filings Older →